Do drugs that stimulate ovulation increase the risk for endometrial stromal sarcoma?
Sir, Reich and Regauer (2004) have made an intriguing observation regarding a preponderance of histories of in vitro fertilization among patients developing endometrial stromal sarcomas (ESS). Although the absence of information as to how long these patients were followed or what types and dosages of drugs they received limits the extent to which a biological connection . . .
